共 128 条
[11]
Smyth DJ(2011)The pathogenesis of systemic sclerosis Annu Rev Pathol 6 509-205
[12]
Bailey R(1988)Scleroderma (systemic sclerosis): classification, subsets and pathogenesis J Rheumatol 15 202-847
[13]
Stahl EA(1996)Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma Br J Dermatol 134 843-649
[14]
Raychaudhuri S(1996)Soluble serum interleukin 2 receptors in patients with systemic sclerosis J Rheumatol 23 646-862
[15]
Remmers EF(2009)IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production PLoS Genet 5 e1000322-2777
[16]
Xie G(2007)Risk alleles for multiple sclerosis identified by a genomewide study N Engl J Med 357 851-530
[17]
Eyre S(2008)Shared and distinct genetic variants in type 1 diabetes and celiac disease N Engl J Med 359 2767-1476
[18]
Thomson BP(1995)Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment Immunity 3 521-1481
[19]
Carr EJ(1995)Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta Science 268 1472-1015
[20]
Clatworthy MR(2009)Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGF beta expression PLoS One 4 e5981-1576